Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects

Recent immunotherapy research has focused on chimeric antigen receptor-modified T cells (CAR-Ts). CAR-T therapies have been clinically applied to manage hematologic malignancies with satisfactory effectiveness. However, the application of CAR-T immunotherapy in solid tumors remains challenging. Even...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Mingze, Zhang, Dongqi, Cao, Yu, Chi, Changliang, Zeng, Zitong, Yang, Xinyi, Yang, Guodong, Sharma, Kritika, Hu, Kebang, Enikeev, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469587/
https://www.ncbi.nlm.nih.gov/pubmed/37664750
http://dx.doi.org/10.1016/j.heliyon.2023.e19147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469587/
https://www.ncbi.nlm.nih.gov/pubmed/37664750
http://dx.doi.org/10.1016/j.heliyon.2023.e19147

Ejemplares similares